Codexis, Inc. (CDXS): Price and Financial Metrics
Codexis, Inc. (CDXS)
Today's Latest Price: $17.90 USD
Updated Nov 24 4:00pm
Add CDXS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CDXS Stock Summary
- CDXS's price/sales ratio is 15.43; that's higher than the P/S ratio of 89.83% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.48 for Codexis Inc; that's greater than it is for only 23.34% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Codexis Inc is reporting a growth rate of 73.15%; that's higher than 85.31% of US stocks.
- If you're looking for stocks that are quantitatively similar to Codexis Inc, a group of peers worth examining would be BCYC, DSPG, PSNL, ONCT, and QUIK.
- CDXS's SEC filings can be seen here. And to visit Codexis Inc's official web site, go to www.codexis.com.
CDXS Stock Price Chart Interactive Chart >
CDXS Price/Volume Stats
| Current price | $17.90 | 52-week high | $18.87 |
| Prev. close | $17.38 | 52-week low | $8.43 |
| Day low | $17.43 | Volume | 297,000 |
| Day high | $18.01 | Avg. volume | 371,064 |
| 50-day MA | $13.90 | Dividend yield | N/A |
| 200-day MA | $12.34 | Market Cap | 1.06B |
Codexis, Inc. (CDXS) Company Bio
Codexis, Inc. develops biocatalysts for the pharmaceutical and fine chemicals markets in the United States and internationally. The company offers Codex biocatalyst panels and kits to pharmaceutical companies that are engaged in drug development and the marketing of approved drugs to allow them to screen and identify possible enzymatic manufacturing processes for their drug candidates and their marketed products. The company was founded in 2002 and is based in Redwood City, California.
Loading social stream, please wait...